Actively Recruiting
Clinicopathological Value of p16 Expression in Colorectal Carcinoma
Led by Sohag University · Updated on 2025-07-10
50
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluation of the immunohistochemical expression of p16 in colorectal carcinoma and correlate its expression to different clinical and pathological parameters as patients' ages, sexes, tumor location, histopathological phenotype, status of nodal involvement, perineural and lymphovascular invasion.
CONDITIONS
Official Title
Clinicopathological Value of p16 Expression in Colorectal Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Specimens from patients with colorectal cancer.
- Tissue blocks with sufficient material.
- Specimens with sufficient clinical data.
You will not qualify if you...
- Tissue blocks with insufficient, destroyed or necrotic material.
- Specimens with insufficient clinical data.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Medicine
Sohag, Recruiting, Egypt
Actively Recruiting
Research Team
S
Sherry R Azmy, Demonstrator of pathology
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here